Cell and Gene Therapy Market Key Highlights:
- Market Size (2024): USD 21.28 Billion
- Projected Market Size (2034): USD 117.17 Billion
- CAGR (2024-2034): 18.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Cell & Gene Therapy Market Definition
The cell & gene therapy market refers to the production, distribution, and use of these therapies which is a medical approach that treats or prevents disease by correcting the underlying genetic problem. These techniques allow doctors to treat disorders by changing a person’s genetic makeup instead of using drugs or surgery. There is a high demand for these therapies in neurology, cardiology, immunology, oncology, musculoskeletal, and dermatology applications that drive the growth of the cell & gene therapy market.
- These therapies are used to treat diseases like cancer or genetic disorders, autoimmune diseases, infectious diseases, and urinary problems. It also helps to repair spinal cord injury and enhance a weakened immune system.
However, the risk factors of the market include regulatory hurdles, high initial investment, regulatory and health assessment challenges, and patent and intellectual property issues that can hinder the growth of the market. The future scope of the market includes innovation, long-term benefits, allowing a more personalized approach to treatment, and revolutionary treatment options that will help the growth of the cell & gene therapy market.
Cell and Gene Therapy Market Segmentation:
By Therapy Type
- Cell Therapy
- Gene Therapy
By Therapeutic class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
By Delivery Method
By End-Users
- Hospitals
- Cancer Care Centers
- Others
Cell and Gene Therapy Market Companies:
- Alnylam Pharmaceuticals Inc.
- Amgen Inc.
- Biogen Inc.
- CORESTEM Inc.
- Dendreon Pharmaceuticals LLC.
- Helixmith Co. Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Kolon TissueGene Inc.
- Novartis AG
- Pfizer Inc.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
-n-butoxide-market.jpg)
